HNSCC tissues produce PD-L1 through an abnormal PD-1 signalling pathway, which leads to tumour immunosuppression [233], with the PD-1/PD-L1 pathway being activated in a chronic inflammatory environment. The gene discussed is PDCD1; the disease is neoplasm.